Compare Royal Bank of Canada (RY) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royal Bank of Canada vs GeneDx Holdings Corp — how do they compare? Royal Bank of Canada trades at $210.37 (market cap $289.51B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Royal Bank of Canada is far larger — about 160.8× GeneDx Holdings Corp's market cap, and Royal Bank of Canada pays a 2.42% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| RY | WGS | |
|---|---|---|
Market Cap | $289.51B | $1.80B |
Sector | Financials | Technology |
52-Week High | $217.87 | $167.51 |
52-Week Low | $128.46 | $34.51 |
Dividend Yield | 2.42% | — |
Enterprise Value | — | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
